IORT-EBRT patients showed a trend to more pain, breast, and arm symptoms compared to IORT alone patients, but did not differ from patients treated with an IORT or EBRT boost outside of the TARGIT trial or EBRT without a boost.
← all excerpts
Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A.
1
—
—